Literature DB >> 31934151

Primary aldosteronism complicated by hyperparathyroidism: report of one case and literature review.

Dandan Zhou1, Min Liu1, Zhaoli Yan1.   

Abstract

Primary aldosteronism (PA) is a category of secondary hypertension induced by inhibition of the renin-angiotensin system due to increased aldosterone secretion. Aldosterone-producing adenoma (APA) is the most common hypotype of PA. Primary hyperparathyroidism (PHPT) refers to the symptoms of increased bone resorption and increased calcium reabsorption of kidney tubules caused by parathyroid secretion and excessive synthesis of parathyroid hormone. APA, complicated with PHPT has been extremely rare in clinical practice. In this study, the diagnosis and treatment of one case of APA complicated by PHPT was reported. Relevant literature review was performed. IJCEP
Copyright © 2019.

Entities:  

Keywords:  Primary aldosteronism; multiple endocrine neoplasia; primary hyperparathyroidism

Year:  2019        PMID： 31934151      PMCID： PMC6949694     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN： 1936-2625


  12 in total

1.  Hyperparathyroidism and the calcium paradox of aldosteronism.

Authors:  Vikram S Chhokar; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Linda K Myers; Zhiqing Xing; Richard A Smith; Ivan C Gerling; Karl T Weber
Journal:  Circulation       Date:  2005-02-14       Impact factor: 29.690

2.  Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.

Authors:  Stefan Pilz; Katharina Kienreich; Christiane Drechsler; Eberhard Ritz; Astrid Fahrleitner-Pammer; Martin Gaksch; Andreas Meinitzer; Winfried März; Thomas R Pieber; Andreas Tomaschitz
Journal:  J Clin Endocrinol Metab       Date:  2011-10-19       Impact factor: 5.958

3.  PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells.

Authors:  G Mazzocchi; F Aragona; L K Malendowicz; G G Nussdorfer
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-02       Impact factor: 4.310

4.  Renal damage in primary aldosteronism: results of the PAPY Study.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Massimo Mannelli; Mee-Jung Matterello; Domenico Montemurro; Gaetana Palumbo; Damiano Rizzoni; Ermanno Rossi; Achille Cesare Pessina; Franco Mantero
Journal:  Hypertension       Date:  2006-06-26       Impact factor: 10.190

5.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

6.  Relative glomerular hyperfiltration in primary aldosteronism.

Authors:  Jean Ribstein; Guilhem Du Cailar; Pierre Fesler; Albert Mimran
Journal:  J Am Soc Nephrol       Date:  2005-03-30       Impact factor: 10.121

7.  Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy.

Authors:  Evelyn Fischer; Gregor Hanslik; Anna Pallauf; Christoph Degenhart; Ulrich Linsenmaier; Felix Beuschlein; Martin Bidlingmaier; Thomas Mussack; Roland Ladurner; Klaus Hallfeldt; Marcus Quinkler; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2012-08-14       Impact factor: 5.958

8.  Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database.

Authors:  B Gatta-Cherifi; O Chabre; A Murat; P Niccoli; C Cardot-Bauters; V Rohmer; J Young; B Delemer; H Du Boullay; M F Verger; J M Kuhn; J L Sadoul; Ph Ruszniewski; A Beckers; M Monsaingeon; E Baudin; P Goudet; A Tabarin
Journal:  Eur J Endocrinol       Date:  2011-11-14       Impact factor: 6.664

9.  Changes in blood pressure and renal function after parathyroidectomy in primary hyperparathyroidism.

Authors:  D B Jones; J H Jones; H J Lloyd; P A Lucas; W E Wilkins; D A Walker
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

10.  Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening.

Authors:  J Waldmann; D K Bartsch; P H Kann; V Fendrich; M Rothmund; P Langer
Journal:  Langenbecks Arch Surg       Date:  2007-01-19       Impact factor: 2.895
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.